Page last updated: 2024-11-05

trimethadione and Substance Withdrawal Syndrome

trimethadione has been researched along with Substance Withdrawal Syndrome in 1 studies

Trimethadione: An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378)
trimethadione : An oxazolidinone that is 1,3-oxazolidine-2,4-dione substituted by methyl groups at positions 3, 5 and 5. It is an antiepileptic agent.

Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.

Research Excerpts

ExcerptRelevanceReference
"Phenytoin was in effective for most withdrawal signs and some signs were made worse."1.26Evaluation of anticonvulsants in barbiturate withdrawal. ( Boisse, NR; Okamoto, M; Rosenberg, HC, 1977)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okamoto, M1
Rosenberg, HC1
Boisse, NR1

Other Studies

1 other study available for trimethadione and Substance Withdrawal Syndrome

ArticleYear
Evaluation of anticonvulsants in barbiturate withdrawal.
    The Journal of pharmacology and experimental therapeutics, 1977, Volume: 202, Issue:2

    Topics: Animals; Anticonvulsants; Behavior, Animal; Cats; Dimethadione; Female; Humans; Male; Pentobarbital;

1977